 Jeffrey Jacot
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 16 | 2025 | 513 | 4.610 |
Why?
| | Amniotic Fluid | 10 | 2025 | 79 | 4.070 |
Why?
| | Tissue Engineering | 7 | 2023 | 426 | 2.380 |
Why?
| | Induced Pluripotent Stem Cells | 5 | 2025 | 248 | 2.170 |
Why?
| | Hydrogels | 9 | 2023 | 680 | 2.120 |
Why?
| | Polyurethanes | 3 | 2021 | 37 | 2.010 |
Why?
| | Fibrin | 6 | 2023 | 88 | 2.010 |
Why?
| | Tissue Scaffolds | 4 | 2023 | 211 | 1.970 |
Why?
| | Stem Cells | 6 | 2015 | 599 | 1.830 |
Why?
| | Cell Differentiation | 12 | 2025 | 1994 | 1.550 |
Why?
| | Myocardium | 6 | 2019 | 921 | 1.440 |
Why?
| | Chitosan | 3 | 2017 | 34 | 1.310 |
Why?
| | Materials Testing | 3 | 2021 | 350 | 1.140 |
Why?
| | Polyethylene Glycols | 5 | 2023 | 631 | 0.980 |
Why?
| | Heart Ventricles | 4 | 2021 | 745 | 0.950 |
Why?
| | Ventricular Function, Left | 2 | 2019 | 502 | 0.860 |
Why?
| | Bioreactors | 1 | 2023 | 48 | 0.810 |
Why?
| | Heart-Assist Devices | 2 | 2019 | 556 | 0.700 |
Why?
| | Human Umbilical Vein Endothelial Cells | 5 | 2023 | 107 | 0.700 |
Why?
| | Pericardium | 2 | 2021 | 56 | 0.680 |
Why?
| | Bioprosthesis | 1 | 2021 | 39 | 0.680 |
Why?
| | Polyesters | 3 | 2021 | 77 | 0.660 |
Why?
| | Endothelial Cells | 3 | 2021 | 790 | 0.640 |
Why?
| | Stem Cell Transplantation | 1 | 2021 | 184 | 0.640 |
Why?
| | Heart | 2 | 2014 | 612 | 0.630 |
Why?
| | Cardiac Output | 1 | 2019 | 177 | 0.600 |
Why?
| | Rats, Sprague-Dawley | 8 | 2019 | 2497 | 0.580 |
Why?
| | Cell Adhesion | 3 | 2014 | 466 | 0.570 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 571 | 0.560 |
Why?
| | Electrocardiography | 3 | 2019 | 610 | 0.550 |
Why?
| | Pluripotent Stem Cells | 1 | 2018 | 80 | 0.550 |
Why?
| | Cells, Cultured | 8 | 2025 | 4182 | 0.550 |
Why?
| | Silicon Dioxide | 1 | 2018 | 115 | 0.540 |
Why?
| | Fetal Stem Cells | 1 | 2017 | 8 | 0.540 |
Why?
| | Ventricular Remodeling | 2 | 2019 | 257 | 0.520 |
Why?
| | Membranes, Artificial | 1 | 2017 | 69 | 0.510 |
Why?
| | Rats | 8 | 2021 | 5591 | 0.510 |
Why?
| | Embryonic Stem Cells | 2 | 2015 | 129 | 0.500 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2016 | 77 | 0.500 |
Why?
| | Animals | 21 | 2021 | 37243 | 0.470 |
Why?
| | Biocompatible Materials | 2 | 2020 | 426 | 0.450 |
Why?
| | Electric Conductivity | 1 | 2014 | 86 | 0.440 |
Why?
| | Capillaries | 1 | 2015 | 114 | 0.430 |
Why?
| | Nanotubes, Carbon | 1 | 2014 | 48 | 0.430 |
Why?
| | Osmium Tetroxide | 1 | 2013 | 1 | 0.420 |
Why?
| | Polymethyl Methacrylate | 1 | 2013 | 22 | 0.410 |
Why?
| | Neovascularization, Physiologic | 1 | 2015 | 182 | 0.410 |
Why?
| | Electron Microscope Tomography | 1 | 2013 | 40 | 0.410 |
Why?
| | Coloring Agents | 1 | 2013 | 95 | 0.410 |
Why?
| | Action Potentials | 1 | 2016 | 485 | 0.400 |
Why?
| | Myocardial Contraction | 4 | 2018 | 303 | 0.400 |
Why?
| | Extracellular Matrix | 2 | 2015 | 539 | 0.400 |
Why?
| | Wnt Signaling Pathway | 1 | 2015 | 197 | 0.390 |
Why?
| | Gap Junctions | 1 | 2013 | 60 | 0.390 |
Why?
| | Microvessels | 1 | 2013 | 86 | 0.390 |
Why?
| | Gelatin | 1 | 2012 | 55 | 0.380 |
Why?
| | Porosity | 3 | 2018 | 99 | 0.340 |
Why?
| | Fibroblasts | 1 | 2014 | 1002 | 0.300 |
Why?
| | Mechanotransduction, Cellular | 1 | 2009 | 110 | 0.290 |
Why?
| | Cell Separation | 3 | 2015 | 317 | 0.280 |
Why?
| | Heart Valves | 2 | 2021 | 42 | 0.270 |
Why?
| | Humans | 21 | 2025 | 138972 | 0.260 |
Why?
| | Saphenous Vein | 1 | 2006 | 36 | 0.250 |
Why?
| | Amniocentesis | 1 | 2025 | 20 | 0.240 |
Why?
| | Cell Line | 2 | 2021 | 2879 | 0.230 |
Why?
| | Troponin T | 2 | 2014 | 65 | 0.210 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 201 | 0.200 |
Why?
| | Cell Shape | 2 | 2014 | 57 | 0.200 |
Why?
| | Water | 1 | 2006 | 461 | 0.200 |
Why?
| | Coculture Techniques | 2 | 2014 | 241 | 0.200 |
Why?
| | Pregnancy | 3 | 2025 | 6870 | 0.190 |
Why?
| | Substrate Specificity | 2 | 2016 | 385 | 0.190 |
Why?
| | Stress, Mechanical | 3 | 2010 | 487 | 0.190 |
Why?
| | Acrylic Resins | 2 | 2016 | 46 | 0.190 |
Why?
| | Cell Communication | 2 | 2014 | 316 | 0.180 |
Why?
| | Heart Failure | 1 | 2015 | 2065 | 0.180 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 148 | 0.180 |
Why?
| | Succinimides | 1 | 2021 | 19 | 0.180 |
Why?
| | Salinity | 1 | 2021 | 19 | 0.180 |
Why?
| | Solvents | 1 | 2021 | 112 | 0.170 |
Why?
| | Sodium Chloride | 1 | 2021 | 138 | 0.170 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2591 | 0.170 |
Why?
| | Animals, Newborn | 2 | 2013 | 859 | 0.160 |
Why?
| | Cross-Linking Reagents | 1 | 2021 | 215 | 0.160 |
Why?
| | Fibrinogen | 1 | 2021 | 173 | 0.160 |
Why?
| | Cell Survival | 2 | 2014 | 1126 | 0.160 |
Why?
| | Chemokines | 1 | 2021 | 226 | 0.160 |
Why?
| | Organ Culture Techniques | 1 | 2020 | 157 | 0.160 |
Why?
| | Bioengineering | 1 | 2018 | 20 | 0.140 |
Why?
| | Electrophysiological Phenomena | 1 | 2018 | 58 | 0.140 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2018 | 82 | 0.140 |
Why?
| | Swine | 1 | 2021 | 800 | 0.140 |
Why?
| | Tensile Strength | 2 | 2010 | 96 | 0.140 |
Why?
| | Cell Proliferation | 2 | 2023 | 2480 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2024 | 569 | 0.140 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 178 | 0.140 |
Why?
| | Wnt Proteins | 1 | 2018 | 135 | 0.140 |
Why?
| | Microscopy, Atomic Force | 2 | 2009 | 127 | 0.140 |
Why?
| | Nanog Homeobox Protein | 1 | 2017 | 13 | 0.130 |
Why?
| | Calcium | 2 | 2016 | 1188 | 0.130 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2017 | 18 | 0.130 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 80 | 0.130 |
Why?
| | Antigens, Surface | 1 | 2017 | 154 | 0.130 |
Why?
| | Mice, Nude | 1 | 2018 | 688 | 0.130 |
Why?
| | Proteoglycans | 1 | 2017 | 109 | 0.130 |
Why?
| | Mice | 4 | 2021 | 17828 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2016 | 123 | 0.120 |
Why?
| | Oncolytic Viruses | 1 | 2016 | 9 | 0.120 |
Why?
| | Patch-Clamp Techniques | 1 | 2016 | 291 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 348 | 0.120 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 117 | 0.120 |
Why?
| | Batch Cell Culture Techniques | 1 | 2015 | 3 | 0.120 |
Why?
| | Adenoviridae | 1 | 2016 | 200 | 0.110 |
Why?
| | Transfection | 1 | 2017 | 942 | 0.110 |
Why?
| | Intestine, Small | 1 | 2015 | 156 | 0.110 |
Why?
| | Genetic Markers | 1 | 2015 | 344 | 0.110 |
Why?
| | Sus scrofa | 1 | 2014 | 58 | 0.110 |
Why?
| | Corrosion Casting | 1 | 2013 | 1 | 0.110 |
Why?
| | Compressive Strength | 1 | 2014 | 77 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6158 | 0.100 |
Why?
| | Diffusion Chambers, Culture | 1 | 2013 | 9 | 0.100 |
Why?
| | Heart Conduction System | 1 | 2014 | 89 | 0.100 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2014 | 310 | 0.100 |
Why?
| | Calsequestrin | 1 | 2013 | 8 | 0.100 |
Why?
| | Organ Specificity | 1 | 2014 | 310 | 0.100 |
Why?
| | Cardiovascular Abnormalities | 1 | 2013 | 13 | 0.100 |
Why?
| | Connexin 43 | 1 | 2013 | 35 | 0.100 |
Why?
| | Prosthesis Design | 1 | 2015 | 333 | 0.100 |
Why?
| | Regenerative Medicine | 1 | 2013 | 52 | 0.100 |
Why?
| | Female | 6 | 2025 | 74016 | 0.100 |
Why?
| | Rabbits | 1 | 2013 | 762 | 0.090 |
Why?
| | Myosin Heavy Chains | 1 | 2013 | 177 | 0.090 |
Why?
| | Endotoxins | 1 | 2012 | 220 | 0.090 |
Why?
| | Tumor Microenvironment | 1 | 2016 | 668 | 0.090 |
Why?
| | Surface Properties | 1 | 2012 | 411 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 665 | 0.090 |
Why?
| | Signal Transduction | 2 | 2015 | 5092 | 0.080 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 449 | 0.080 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 365 | 0.080 |
Why?
| | Protein Transport | 1 | 2012 | 443 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 620 | 0.080 |
Why?
| | Embryo, Mammalian | 1 | 2009 | 236 | 0.070 |
Why?
| | Models, Biological | 1 | 2016 | 1810 | 0.070 |
Why?
| | Cell Movement | 1 | 2012 | 969 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2012 | 1192 | 0.070 |
Why?
| | Age Factors | 1 | 2015 | 3276 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4095 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2012 | 892 | 0.060 |
Why?
| | Compliance | 1 | 2006 | 50 | 0.060 |
Why?
| | Lung | 1 | 2020 | 4103 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4316 | 0.060 |
Why?
| | Elasticity | 1 | 2006 | 194 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2013 | 1063 | 0.060 |
Why?
| | Adult | 2 | 2025 | 38393 | 0.060 |
Why?
| | Male | 4 | 2020 | 68250 | 0.060 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.050 |
Why?
| | Plasma | 1 | 2024 | 220 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2687 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 10921 | 0.040 |
Why?
| | Child, Preschool | 1 | 2015 | 11158 | 0.040 |
Why?
| | Peptides | 1 | 2024 | 980 | 0.040 |
Why?
| | Adolescent | 1 | 2015 | 21581 | 0.030 |
Why?
| | Stromal Cells | 1 | 2016 | 112 | 0.030 |
Why?
| | Aged | 1 | 2015 | 24172 | 0.030 |
Why?
| | Child | 1 | 2015 | 21936 | 0.030 |
Why?
| | Mice, SCID | 1 | 2016 | 368 | 0.030 |
Why?
| | Organoids | 1 | 2016 | 119 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2016 | 501 | 0.030 |
Why?
| | Middle Aged | 1 | 2015 | 33782 | 0.020 |
Why?
| | Sheep | 1 | 2015 | 864 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1045 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1765 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5801 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 3397 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1857 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3143 | 0.020 |
Why?
|
|
Jacot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|